This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Leidos Wins a $51M Deal to Upgrade Missile Capabilities
by Zacks Equity Research
LDOS gets a $51 million contract from Space Systems Command, Strategic Warning and Surveillance Systems Acquisition Delta for improving missile capabilities.
Here's How Much You'd Have If You Invested $1000 in Leidos a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Leidos Holdings, Inc. (LDOS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Leidos (LDOS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Leidos (LDOS) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Leidos Holdings, Inc. (LDOS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Leidos (LDOS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks.com featured highlights Leidos, Trane, Cabot, Vertiv and Charles River
by Zacks Equity Research
Leidos, Trane, Cabot, Vertiv and Charles River have been highlighted in this Screen of The Week article.
Bet on These 4 Stocks With Exciting Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. LDOS, STRL, HRB & LRN are sound enough to meet financial obligations.
5 Dividend Growth Stocks to Boost Your Portfolio
by Sweta Killa
Leidos Holdings (LDOS), Trane Technologies (TT), Cabot Corporation (CBT), Vertiv Holdings (VRT) and Charles River (CRAI) could be solid choices for your portfolio.
Reasons to Add Leidos (LDOS) Stock to Your Portfolio Now
by Zacks Equity Research
Leidos (LDOS) makes a strong case for investment in the Aerospace sector, given its solid earnings growth prospects and rising backlog.
Here is Why Growth Investors Should Buy Leidos (LDOS) Now
by Zacks Equity Research
Leidos (LDOS) possesses solid growth attributes, which could help it handily outperform the market.
Why Leidos (LDOS) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Aerospace Stocks Lagging Kratos Defense & Security Solutions (KTOS) This Year?
by Zacks Equity Research
Here is how Kratos (KTOS) and Leidos (LDOS) have performed compared to their sector so far this year.
Lockheed (LMT) Surges 24% YTD: Should You Buy Now or Later?
by Aparajita Dutta
A prudent investor should refrain from buying Lockheed (LMT) now, considering its premium valuation. Those who own it might continue to do so.
CACI International (CACI) Secures Army Contract Worth $239M
by Zacks Equity Research
CACI International (CACI) secures a contract worth $239 million from the U.S. Army to provide intelligence support throughout Europe and Africa.
Science Applications (SAIC) Secures Navy Contracts Worth $58.2M
by Zacks Equity Research
Science Applications (SAIC) secures three Navy contracts worth $58.2 million, which are set to provide support for the Navy's jammer assets and electronic warfare programs.
Leidos (LDOS) Wins a $191M Deal to Upgrade US Army's Software
by Zacks Equity Research
Leidos (LDOS) gets a $191 million contract for software modernization to support the U.S. Army.
Science Applications (SAIC) Secures Navy Contract Worth $120M
by Zacks Equity Research
Science Applications (SAIC) secures a $120 million contract from Naval Supply Systems Command to support the latter's fleet training missions.
Is It Worth Investing in Leidos (LDOS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Leidos (LDOS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LDOS vs. EADSY: Which Stock Is the Better Value Option?
by Zacks Equity Research
LDOS vs. EADSY: Which Stock Is the Better Value Option?
Why Leidos (LDOS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Leidos Holdings, Inc. (LDOS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Leidos (LDOS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks.com featured highlights include Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare
by Zacks Equity Research
Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare have been highlighted in this Screen of The Week article.
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.
Leidos (LDOS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Leidos (LDOS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks.com featured highlights include HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies
by Zacks Equity Research
HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies are part of the Zacks Screen of the Week article.